• Imatinib (STI571): Streamlining Tumor Microenvironment Assay

  2026-08-06

  Imatinib (STI571) empowers researchers to dissect tyrosine kinase signaling in complex tumor models, enabling high-fidelity signal transduction and cancer biology research. Discover protocol enhancements, troubleshooting strategies, and the impact of stromal components on kinase inhibitor response.

• Oscillatory mTORC1 Dynamics Govern Mitotic Entry and Autopha

  2026-08-06

  Joshi et al. reveal that mTORC1 activity oscillates across the cell cycle, peaking in S/G2 and reaching its lowest in mitosis and G1. This dynamic regulation shapes mitotic entry and modulates sensitivity to autophagy, providing new mechanistic insights into cell cycle control and metabolic adaptation in proliferating cells.

• Myriocin: Potent Serine Palmitoyltransferase Inhibitor for S

  2026-08-05

  Myriocin is a highly selective inhibitor of serine palmitoyltransferase (SPT) employed in sphingolipid metabolism research. It effectively blocks de novo sphingolipid biosynthesis, yielding robust immunosuppressive and antiproliferative effects in oncology and immunology models. This article details its molecular mechanism, validated benchmarks, and practical workflow integration.

• Deferasirox Fe3+ Chelate: Advanced Workflows in Iron Overloa

  2026-08-05

  Deferasirox Fe3+ chelate enables precise modeling of iron overload and myeloid differentiation, thanks to its robust Fe3+ binding and exceptional DMSO solubility. This article unpacks optimized lab protocols, troubleshooting guidance, and the latest mechanistic insights for researchers studying iron metabolism and hematopoietic modulation.

• GATA6 Loss Drives Lineage Plasticity and Metastasis in CRC

  2026-08-04

  This study reveals that loss of the transcription factor GATA6 triggers multilineage plasticity and enhances liver metastasis in colorectal cancer (CRC), independent of primary tumor growth. By employing a pro-metastatic CRC organoid library and integrative genomic analyses, the research identifies GATA6 as a central epigenetic regulator of metastatic progression, with implications for targeting lineage plasticity in advanced CRC.

• Tris(2-carboxyethyl) Phosphine Hydrochloride: Workflow and I

  2026-08-04

  Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is transforming protein analysis, redox workflows, and advanced biochemical assays by offering stable, odorless, and selective disulfide reduction. Here, we dissect how TCEP hydrochloride, supplied by APExBIO, underpins next-generation experimental protocols and troubleshooting for researchers seeking reliable results.

• Predicting Compound Mechanism of Action Across Cell Lines Us

  2026-08-03

  Warchal et al. evaluated how machine learning classifiers can predict the mechanism of action (MoA) of compounds, such as Simvastatin, when applied to morphologically and genetically distinct cell lines using high-content imaging data. Their work highlights both the promise and current limitations of transferring ML-driven phenotypic profiling across diverse cellular contexts, informing experimental strategies for drug discovery and functional genomics.

• WM-8014: High-Precision KAT6A Inhibitor for Epigenetic Resea

  2026-08-03

  WM-8014 enables researchers to dissect selective histone acetyltransferase inhibition, allowing robust oncogene-induced senescence and cell cycle arrest assays without generalized cytotoxicity. Its nanomolar potency and reversible competitive mechanism make it a leading choice for advanced cancer biology and epigenetic workflows.

• Tacalcitol Monohydrate: Mechanistic Insights and Oncology Pr

  2026-08-02

  Explore Tacalcitol monohydrate, a synthetic analog of vitamin D3, through a deep dive into its molecular mechanisms and practical usage in cancer and dermatology research. This article uniquely dissects recent mechanistic breakthroughs and protocol strategies for advanced assay development.

• Carvedilol Phosphate in Hepatic Ischemia–Reperfusion Researc

  2026-08-01

  Carvedilol Phosphate, a high-purity non-selective beta blocker, is advancing hepatic ischemia–reperfusion injury (IRI) models by enabling robust modulation of adrenergic signaling. This article details stepwise experimental workflows, protocol optimizations, and troubleshooting approaches that leverage APExBIO’s Carvedilol Phosphate for reproducible outcomes in cardiovascular pharmacology research.

• Remdesivir (GS-5734): Optimizing Antiviral Workflows for RNA

  2026-07-31

  Remdesivir (GS-5734) is a benchmark tool for translational coronavirus and Ebola antiviral research, offering robust inhibition of RNA viruses in both cellular and animal models. This guide delivers actionable protocol enhancements, troubleshooting strategies, and a practical bridge from reference breakthroughs to daily virology lab success.

• Quercetin Suppresses Ferroptosis in Wilson’s Disease Liver I

  2026-07-31

  This study demonstrates that quercetin alleviates liver injury in Wilson’s disease models by directly inhibiting ferroptosis through the ACSL4/LPCAT3/ALOX15 pathway. The findings highlight a mechanistic advance for using quercetin as a multi-target modulator of iron homeostasis, lipid peroxidation, and mitochondrial function in metal-induced hepatic disorders.

• Dinaciclib (SCH727965): Advancing Tissue Boundary Research i

  2026-07-30

  Explore how Dinaciclib (SCH727965), a potent multi-CDK inhibitor, bridges mechanistic insights from developmental biology to translational oncology by enabling precise dissection of cell cycle and tissue boundary dynamics. This article synthesizes recent discoveries in Drosophila boundary formation with actionable guidance for cancer research, highlighting strategic applications and protocol considerations for translational investigators.

• Mc-Val-Cit-PABC-PNP: Protocol and Workflow Guidance for ADCs

  2026-07-30

  Mc-Val-Cit-PABC-PNP is a cathepsin B-cleavable ADC peptide linker designed for organic solvent-based antibody-drug conjugate synthesis, enabling selective lysosomal payload release in targeted drug delivery research. It is not suitable for aqueous workflows, diagnostic, or clinical applications, requiring strict adherence to solubility and storage protocols.

• Nanoparticle Uptake in Corneal Cells: Size, Surface, and Mec

  2026-07-29

  This study by Azadi and David systematically dissects how nanoparticle size and surface chemistry govern their uptake by human corneal epithelial cells. Detailed mechanistic insights into endocytic pathways provide a foundation for rational design of advanced ocular drug delivery systems.

16065 records 1/1071 page Next 12345 下5页 Last page